2026 Investor Deck · page 2 of 15
Includes specific disclaimer about ivonescimab regulatory status and copyright information.
Consulting deck · appendix_disclosure · other · balanced density
Slide locked Sign in to view
Slide schematic 3/3
disclaimer 2/2 title 1/1
Components 3
disclaimer disclaimer headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.